About FDA
Percentage of FDA advisory committee meetings during the month, that were identified as needing a Patient Representative, that had a Patient Representative (1)
Dictionary: Patient Representatives participate in advisory committee meetings to ensure patient input on important medical product review and policy questions.
The Patient Representative’s role is to provide the advisory committee and FDA insight on issues, problems, and/or questions pertinent to the unique viewpoint of patients living with a specific disease.
Fiscal Year - 2010
| Time | Target | Percent |
|---|---|---|
| Oct 2009 | 80 | 83 |
| Nov 2009 | 80 | 63 |
| Dec 2009 | 80 | 70 |
| Jan 2010 | 80 | 100 |
| Feb 2010 | 80 | 67 |
| Mar 2010 | 80 | 60 |
| Apr 2010 | 80 | 100 |
| May 2010 | 80 | 100 |
| Jun 2010 | 80 | 50 |
| Jul 2010 | 80 | 88 |
| Aug 2010 | 80 | 100 |
| Sep 2010 | 80 | 100 |
FY 2010 Overall: 73%
Footnotes
- (1) This measure will no longer be tracked after April 2012.
Number of FDA advisory committee meetings during the month that had a Patient Representative (1)
Fiscal Year - 2010
| Time | Target | Number |
|---|---|---|
| Oct 2009 | N/A | 5 |
| Nov 2009 | N/A | 5 |
| Dec 2009 | N/A | 7 |
| Jan 2010 | N/A | 2 |
| Feb 2010 | N/A | 2 |
| Mar 2010 | N/A | 6 |
| Apr 2010 | N/A | 3 |
| May 2010 | N/A | 4 |
| Jun 2010 | N/A | 3 |
| Jul 2010 | N/A | 7 |
| Aug 2010 | N/A | 4 |
| Sep 2010 | N/A | 6 |
FY 2010 Total: 64
Number of FDA advisory committee meetings during the month, that were identified as needing a Patient Representative, that had a Patient Representative (1)
Fiscal Year - 2010
| Time | Target | Number |
|---|---|---|
| Oct 2009 | N/A | 6 |
| Nov 2009 | N/A | 8 |
| Dec 2009 | N/A | 10 |
| Jan 2010 | N/A | 2 |
| Feb 2010 | N/A | 3 |
| Mar 2010 | N/A | 10 |
| Apr 2010 | N/A | 3 |
| May 2010 | N/A | 4 |
| Jun 2010 | N/A | 6 |
| Jul 2010 | N/A | 8 |
| Aug 2010 | N/A | 4 |
| Sep 2010 | N/A | 6 |
FY 2010 Total: 88
Total number of advisory committee meetings during the month (1)
Fiscal Year - 2010
| Time | Target | Number |
|---|---|---|
| Oct 2009 | N/A | 8 |
| Nov 2009 | N/A | 9 |
| Dec 2009 | N/A | 12 |
| Jan 2010 | N/A | 3 |
| Feb 2010 | N/A | 4 |
| Mar 2010 | N/A | 11 |
| Apr 2010 | N/A | 6 |
| May 2010 | N/A | 5 |
| Jun 2010 | N/A | 7 |
| Jul 2010 | N/A | 11 |
| Aug 2010 | N/A | 5 |
| Sep 2010 | N/A | 8 |
FY 2010 Total: 89
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
